nach oben

Erschienen in:

11.08.2023 | Urology - Original Paper

Protective potential of pterostilbene against cyclophosphamide-induced nephrotoxicity and cystitis in rats

verfasst von: Gökçen Kerimoğlu, Tuğba Arıcı, Ayşe Firuze Bıyık, Ali Kulaber, Nihal Türkmen Alemdar, Selim Demir, Yüksel Aliyazıcıoğlu, Engin Yenilmez

Erschienen in: International Urology and Nephrology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Cyclophosphamide (CYP) is an antitumor drug. However, in addition to its antitumor affect, CYP can also lead to nephrotoxicity and hemorrhagic cystitis. The purpose of this study was to investigate the potential protective effects of Pterostilbene (Pte), a natural antioxidant as a resveratrol analog against CYP-induced nephrotoxicity and cystitis in rats.

Methods

Twenty-one male Sprague Dawley rats were divided into 3 equal groups. The control group and the CYP group (CYPG) received 1 ml/kg sunflower oil per day, and the CYP + Pte group (CYP + PteG) 40 mg/kg per day Pte dissolved in sunflower oil once a day via the oral route for 14 days. In addition, on day 9 of the experiment, CYPG and CYP + PteG received a single dose of 200 mg/kg CYP dissolved in saline solution, while the control group received a single dose of 10 ml/kg saline solution, via the intraperitoneal route. Bladder and kidney tissues were collected for histological and biochemical evaluations.

Results

Pte was observed to reduce CYP-derived increases in malondialdehyde level, total oxidant status (TOS), the oxidative stress index (OSI), and apoptosis in kidney tissues and to cause an increase in superoxide dismutase levels. It also reduced CYP-derived increases in TOS, OSI, and apoptosis in bladder tissue. Moreover, Pte also ameliorated histopathological findings associated with CYP-induced tissue damage in both the kidney and bladder.

Conclusion

Our study findings show that Pte may exhibit a protective effect against CYP-induced nephrotoxicity and cystitis.

Ogino MH, Tadi P (2022) Cyclophosphamide. In: StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553087/. Accessed 19 May 2023

Ayza MA, Zewdie KA, Yigzaw EF et al (2022) Potential protective effects of antioxidants against cyclophosphamide-induced nephrotoxicity. Int J Nephrol 51:803–810. https://doi.org/10.1155/2022/5096825CrossRef

Hansen RJ, Ludeman SM, Paikoff SJ et al (2007) Role of MGMT in protecting against cyclophosphamide-induced toxicity in cells and animals. DNA Repair 6(8):1145–1154. https://doi.org/10.1016/j.dnarep.2007.03.010CrossRefPubMedPubMedCentral

Alam MF, Ajeibi AO, Safhi MH et al (2023) Therapeutic potential of capsaicin against cyclophosphamide-induced liver damage. J Clin Med 12(3):911. https://doi.org/10.3390/jcm12030911CrossRefPubMedPubMedCentral

Hassanein EHM, Kamel EO, Gad-Elrab WM et al (2023) Lansoprazole attenuates cyclophosphamide-induced cardiopulmonary injury by modulating redox-sensitive pathways and inflammation. Mol Cell Biochem. https://doi.org/10.1007/s11010-023-04662-x.Advanceonlinepublication.10.1007/s11010-023-04662-xCrossRefPubMedPubMedCentral

Alshahrani S, Ali Thubab HM, Ali Zaeri AM et al (2022) The protective effects of Sesamin against cyclophosphamide-induced nephrotoxicity through modulation of oxidative stress, inflammatory-cytokines and apoptosis in rats. Int J Mol Sci 23(19):11615. https://doi.org/10.3390/ijms231911615CrossRefPubMedPubMedCentral

Ayhanci A, Tanriverdi DT, Sahinturk V et al (2020) Protective effects of boron on cyclophosphamide-induced bladder damage and oxidative stress in rats. Biol Trace Elem Res 197(1):184–191. https://doi.org/10.1007/s12011-019-01969-zCrossRefPubMed

Zirak MR, Karimi G, Rahimian R et al (2020) Tropisetron ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats. Eur J Pharmacol 883:173310. https://doi.org/10.1016/j.ejphar.2020.173310CrossRefPubMed

Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4(2):89–96PubMedPubMedCentral

10.

Phaniendra A, Jestadi DB, Periyasamy L (2015) Free radicals: properties, sources, targets, and their implication in various diseases. Indian J Clin Biochem 30(1):11–26. https://doi.org/10.1007/s12291-014-0446-0CrossRefPubMed

11.

Hajam YA, Rani R, Ganie SY et al (2022) Oxidative stress in human pathology and aging: molecular mechanisms and perspectives. Cells 11(3):552. https://doi.org/10.3390/cells11030552CrossRefPubMedPubMedCentral

12.

Nagarajan S, Mohandas S, Ganesan K et al (2022) New insights into dietary Pterostilbene: sources, metabolism, and health promotion effects. Molecules (Basel, Switzerland) 27(19):6316. https://doi.org/10.3390/molecules27196316CrossRefPubMed

13.

Kapetanovic IM, Muzzio M, Huang Z et al (2011) Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother Pharmacol 68(3):593–601. https://doi.org/10.1007/s00280-010-1525-4CrossRefPubMed

14.

McCormack D, McFadden D (2013) A review of pterostilbene antioxidant activity and disease modification. Oxid Med Cell Longev 2013:575482. https://doi.org/10.1155/2013/575482CrossRefPubMedPubMedCentral

15.

Estrela JM, Ortega A, Mena S et al (2013) Pterostilbene: biomedical applications. Crit Rev Clin Lab Sci 50(3):65–78. https://doi.org/10.3109/10408363.2013.805182CrossRefPubMed

16.

Li YR, Li S, Lin CC (2018) Effect of resveratrol and Pterostilbene on aging and longevity. BioFactors 44(1):69–82. https://doi.org/10.1002/biof.1400CrossRefPubMed

17.

Xia Y, Chen Y, Tang L et al (2018) Pterostilbene attenuates acute kidney injury in septic mice. Exp Ther Med 15(4):3551–3555. https://doi.org/10.3892/etm.2018.5808CrossRefPubMedPubMedCentral

18.

Zhang Y, Ren S, Ji Y, Liang Y (2019) Pterostilbene ameliorates nephropathy injury in Streptozotocin-induced diabetic rats. Pharmacology 104(1–2):71–80. https://doi.org/10.1159/000500293CrossRefPubMed

19.

Abd El Tawab AM, Shahin NN, AbdelMohsen MM (2014) Protective effect of Satureja montana extract on cyclophosphamide-induced testicular injury in rats. Chem Biol Interact 224:196–205. https://doi.org/10.1016/j.cbi.2014.11.001CrossRefPubMed

20.

Li Y, Wang SM, Li X et al (2022) Pterostilbene pre-treatment reduces LPS-induced acute lung injury through activating NR4A1. Pharm Biol 60(1):394–403. https://doi.org/10.1080/13880209.2022.2034893CrossRefPubMedPubMedCentral

21.

Sancak EB, Akbas A, Silan C et al (2016) Protective effect of syringic acid on kidney ischemia reperfusion injury. Ren Fail 38(4):629–635. https://doi.org/10.3109/0886022X.2016.1149868CrossRefPubMed

22.

Engin S, Barut EN, Barut B et al (2019) Uroprotective effect of pantoprazole against cyclophosphamide-induced cystitis in mice. Support Care Cancer 27(11):4273–4281. https://doi.org/10.1007/s00520-019-04731-2CrossRefPubMed

23.

Kerimoglu G, Guney C, Ersoz S, Odaci E (2018) A histopathological and biochemical evaluation of oxidative injury in the sciatic nerves of male rats exposed to a continuous 900-megahertz electromagnetic field throughout all periods of adolescence. J Chem Neuroanat 91:1–7. https://doi.org/10.1016/j.jchemneu.2018.01.001CrossRefPubMed

24.

Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86(1):271–278. https://doi.org/10.1016/0003-2697(78)90342-1CrossRefPubMed

25.

Mentese A, Alemdar NT, Livaoglu A et al (2022) Suppression of cisplatin-induced ovarian injury in rats by chrysin: an experimental study. J Obstet Gynaecol 42(8):3584–3590. https://doi.org/10.1080/01443615.2022.2130201CrossRefPubMed

26.

World Health Organization (WHO) (2022) Cancer. WHO Web. https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 19 May 2023

27.

Emadi A, Jones RJ, Brodsky RA (2009) Cyclophosphamide and cancer: golden anniversary. Nat Rev Clin Oncol 6(11):638–647. https://doi.org/10.1038/nrclinonc.2009.146CrossRefPubMed

28.

Santos MLC, de Brito BB, da Silva FAF et al (2020) Nephrotoxicity in cancer treatment: an overview. World J Clin Oncol 11(4):190–204. https://doi.org/10.5306/wjco.v11.i4.190CrossRefPubMedPubMedCentral

29.

Ijaz MU, Mustafa S, Batool R et al (2022) Ameliorative effect of herbacetin against cyclophosphamide-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Hum Exp Toxicol 41:9603271221132140. https://doi.org/10.1177/09603271221132140CrossRefPubMed

30.

Keles I, Bozkurt MF, Cemek M et al (2014) Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna. Int Urol Nephrol 46(12):2301–2310. https://doi.org/10.1007/s11255-014-0833-8CrossRefPubMed

31.

Abdelrahman RS, Nashar EME, Alghamdi MA et al (2023) Phosphodiesterase1 inhibitor “Vinpocetine” ameliorates the inflammation, apoptosis and oxidative stress induced by cyclophosphamide in urinary bladder: an experimental study. Int Urol Nephrol 55(1):129–139. https://doi.org/10.1007/s11255-022-03246-wCrossRefPubMed

32.

Temel Y, Kucukler S, Yıldırım S et al (2020) Protective effect of chrysin on cyclophosphamide-induced hepatotoxicity and nephrotoxicity via the inhibition of oxidative stress, inflammation, and apoptosis. Naunyn Schmiedebergs Arch Pharmacol 393(3):325–337. https://doi.org/10.1007/s00210-019-01741-zCrossRefPubMed

33.

Acharya JD, Ghaskadbi SS (2013) Protective effect of Pterostilbene against free radical mediated oxidative damage. BMC Complement Altern Med 13:238. https://doi.org/10.1186/1472-6882-13-238CrossRefPubMedPubMedCentral

34.

Taghiabadi E, Imenshahidi M, Abnous K et al (2012) Protective effect of silymarin against acrolein-ınduced cardiotoxicity in mice. Evid Based Complement Alternat Med 2012:352091. https://doi.org/10.1155/2012/352091CrossRefPubMedPubMedCentral

35.

Barut EN, Engin S, Barut B et al (2019) Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice. Int Urol Nephrol 51(5):803–810. https://doi.org/10.1007/s11255-019-02128-yCrossRefPubMed

36.

Akbas N, Suleyman B, Mammadov R et al (2022) Effect of taxifolin on cyclophosphamide-induced oxidative and inflammatory bladder injury in rats. Exp Anim 71(4):460–467. https://doi.org/10.1538/expanim.22-0030CrossRefPubMedPubMedCentral

37.

Pisoschi AM, Pop A (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem 97:55–74. https://doi.org/10.1016/j.ejmech.2015.04.040CrossRefPubMed

38.

Merwid-Lad A, Ziolkowski P, Szandruk-Bender M et al (2021) Effect of a low dose of carvedilol on cyclophosphamide-induced urinary toxicity in rats-A comparison with Mesna. Pharm Basel 14(12):1237. https://doi.org/10.3390/ph14121237CrossRef

39.

Gunes S, Sahinturk V, Uslu S et al (2018) Protective effects of selenium on cyclophosphamide-induced oxidative stress and kidney injury. Biol Trace Elem Res 185(1):116–123. https://doi.org/10.1007/s12011-017-1231-8CrossRefPubMed

40.

Gao D, Jing S, Zhang Q, Wu G (2018) Pterostilbene protects against acute renal ischemia reperfusion injury and inhibits oxidative stress, inducible nitric oxide synthase expression and inflammation in rats via the Toll-like receptor 4/nuclear factor-κB signaling pathway. Exp Ther Med 15(1):1029–1035. https://doi.org/10.3892/etm.2017.5479CrossRefPubMed

41.

Tasca S, Campos C, Lacerda D et al (2022) Pterostilbene reduces experimental myocardial infarction-induced oxidative stress in lung and right ventricle. Arq Bras Cardiol 118(2):435–445. https://doi.org/10.36660/abc.20201155CrossRefPubMedPubMedCentral

42.

Sinanoglu O, Yener AN, Ekici S et al (2012) The protective effects of spirulina in cyclophosphamide induced nephrotoxicity and urotoxicity in rats. Urology 80(6):1392.e1–6. https://doi.org/10.1016/j.urology.2012.06.053CrossRefPubMed

43.

Voelcker G (2020) Causes and possibilities to circumvent cyclophosphamide toxicity. Anticancer Drugs 31(6):617–622. https://doi.org/10.1097/CAD.0000000000000912CrossRefPubMed

44.

Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35(4):495–516. https://doi.org/10.1080/01926230701320337CrossRefPubMedPubMedCentral

45.

Yadav V, Krishnan A, Zahiruddin S et al (2023) Amelioration of cyclophosphamide-induced DNA damage, oxidative stress, and hepato- and neurotoxicity by Piper longum extract in rats: The role of γH2AX and 8-OHdG. Front Pharmacol 14:1147823. https://doi.org/10.3389/fphar.2023.1147823CrossRefPubMedPubMedCentral

46.

Luan Y, Edmonds ME, Woodruff TK, Kim SY (2019) Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. J Endocrinol 240(2):243–256. https://doi.org/10.1530/JOE-18-0370CrossRefPubMedPubMedCentral

47.

Rezaei S, Hosseinimehr SJ, Zargari M et al (2023) Sinapic acid attenuates cyclophosphamide-induced liver toxicity in mice by modulating oxidative stress, NF-κB, and caspase-3. Iran J Basic Med Sci 26(5):526–531. https://doi.org/10.22038/IJBMS.2023.68579.14960CrossRefPubMedPubMedCentral

48.

Xiong X, Lu W, Zhang K, Zhou W (2020) Pterostilbene reduces endothelial cell apoptosis by regulation of the Nrf2-mediated TLR-4/MyD88/NF-κB pathway in a rat model of atherosclerosis. Exp Ther Med 20(3):2090–2098. https://doi.org/10.3892/etm.2020.8923CrossRefPubMedPubMedCentral

49.

Tang T, Duan Z, Xu J et al (2020) Pterostilbene reduces endothelial cell injury in vascular arterial walls by regulating the Nrf2-mediated AMPK/STAT3 pathway in an atherosclerosis rat model. Exp Ther Med 19(1):45–52. https://doi.org/10.3892/etm.2019.8211CrossRefPubMed

50.

Ozatik FY, Ozatik O, Teksen Y et al (2021) Protective and therapeutic effect of hydrogen sulfide on hemorrhagic cystitis and testis dysfunction induced with cyclophosphamide. Turk J Med Sci 51(3):1531–1543. https://doi.org/10.3906/sag-2003-10CrossRefPubMed

51.

Engin S, Barut EN, Yaşar YK et al (2022) Trimetazidine attenuates cyclophosphamide-induced cystitis by inhibiting TLR4-mediated NFκB signaling in mice. Life Sci 301:120590. https://doi.org/10.1016/j.lfs.2022.120590CrossRefPubMed

52.

El-Sheikh AA, Morsy MA, Okasha AM (2017) Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacol Immunotoxicol 39(4):180–187. https://doi.org/10.1080/08923973.2017.1318913CrossRefPubMed

Titel: Protective potential of pterostilbene against cyclophosphamide-induced nephrotoxicity and cystitis in rats
verfasst von: Gökçen Kerimoğlu
Tuğba Arıcı
Ayşe Firuze Bıyık
Ali Kulaber
Nihal Türkmen Alemdar
Selim Demir
Yüksel Aliyazıcıoğlu
Engin Yenilmez
Publikationsdatum: 11.08.2023
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 12/2023
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-023-03735-6

Measures of frequency and effect in clinical research

Open Access
Nephrology - Review

Value of the newly developed pelvic dimension index/prostate volume ratio in predicting positive surgical margin in prostate cancer

Urology - Original Paper

Application of image overlapping in percutaneous nephrolithotomy

Urology - Original Paper

Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study

Open Access
Nephrology - Original Paper

Solubility of crystals in acetone: a diagnostic tool for crystalluria

Nephrology - Letter to the Editor

Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients

Open Access
Nephrology - Original Paper

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

10.01.2025
Mammakarzinom
Nachrichten

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

10.01.2025
COPD
Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

Kaffeegenuss sicher bei Vorhofflimmern

10.01.2025
Kaffeekonsum und die Folgen
Nachrichten

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

10.01.2025
Antiemetische Therapie
Nachrichten

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Jetzt 10 CME-Punkte sammeln

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Protective potential of pterostilbene against cyclophosphamide-induced nephrotoxicity and cystitis in rats